Cellames Inc is an innovative bioelectronics technology company that develops MEA (Micro Electrode Array) systems
to capture electrophysiological signals from cardiac and nerve cells, enabling the identification and analysis of
cellular responses to drug toxicity. The company also develops impedance measurement systems to non-destructively
monitor cell proliferation, differentiation, death, toxicity, and drug effects in real time.
We have developed a disk electrode array plate that is easy to observe under a microscope using transparent disk electrodes,
providing a useful tool for cell research and analysis. In particular, we are developing a system that can overcome
ethical issues and interspecies differences by conducting toxicity and efficacy evaluations of new drug development
and test substances using human induced pluripotent stem cells (HiPSCs) rather than animals.
This system can be applied to animal replacement testing methods, and we hope to contribute to the development of human
society through this.